| mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-05 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
9e-05 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.0004 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0004 |
| mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0004 |
| mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |